Scientific article
Open access

Molecular imaging of acute graft-versus-host disease

Published inThe Journal of nuclear medicine, vol. 65, no. 3, p. 357-361
Publication date2024-02-15
First online date2024-02-15

Noninvasive molecular imaging of acute graft-versus-host disease (GvHD) after allogeneic hematopoietic stem cell transplantation has great potential to detect GvHD at the early stages, aid in grading of the disease, monitor treatment response, and guide therapeutic decisions. Although the specificity of currently available tracers appears insufficient for clinical GvHD diagnosis, recently, several preclinical studies have identified promising new imaging agents targeting one or more biologic processes involved in GvHD pathogenesis, ranging from T-cell activation to tissue damage. In this review, we summarize the different approaches reported to date for noninvasive detection of GvHD using molecular imaging with a specific focus on the use of PET. We discuss possible applications of molecular imaging for the detection of GvHD in the clinical setting, as well as some of the predictable challenges that are faced during clinical translation of these approaches.

  • PET/CT
  • Clinical
  • Graft-versus-host disease
  • Hematology
  • Molecular imaging
  • Preclinical
Citation (ISO format)
BERNARDI, Chiara et al. Molecular imaging of acute graft-versus-host disease. In: The Journal of nuclear medicine, 2024, vol. 65, n° 3, p. 357–361. doi: 10.2967/jnumed.123.266552
Main files (1)
Article (Published version)
ISSN of the journal0161-5505

Technical informations

Creation02/23/2024 9:35:36 AM
First validation04/29/2024 8:42:29 AM
Update time04/29/2024 8:42:29 AM
Status update04/29/2024 8:42:29 AM
Last indexation05/06/2024 6:28:47 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack